Literature DB >> 25582519

Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.

X Li1, J Chen, L Zhang, H Liu, S Wang, X Chen, J Fang, S Wang, W Zhang.   

Abstract

OBJECTIVE: To analyse the pattern and factors that influence the incidence of adverse drug reactions (ADRs) induced by non-ionic iodinated contrast media and to evaluate their safety profiles.
METHODS: Data from 109,255 cases who underwent enhanced CT examination from 1 January 2008 to 31 August 2013 were analysed. ADRs were classified according to the criteria issued by the American College of Radiology and the Chinese Society of Radiology.
RESULTS: A total of 375 (0.34%) patients had ADRs, including 281 mild (0.26%); 80 moderate (0.07%); and 14 severe (0.01%) ADRs; no death was found. 302 (80.53%) of the ADRs occurred within 15 min after examination. Patients aged 40-49 years (204 cases, 0.43%; p < 0.01) or who underwent coronary CT angiography (93 cases, 0.61%; p < 0.01) were at a higher risk of ADRs. Female patients (180 cases, 0.40%; p < 0.01) or outpatients had significantly higher incidence rates of ADRs. The symptoms and signs of most of the ADRs were resolved spontaneously within 24 h after appropriate treatment without sequelae.
CONCLUSION: The occurrence of ADRs is caused by the combined effects of multiple factors. The ADRs induced by non-ionic iodinated contrast media are mainly mild ones, while moderate or severe ADRs are relatively rare, suggesting that enhanced CT examination with non-ionic iodinated contrast media is highly safe, and severe adverse events will seldom occur under appropriate care. ADVANCES IN KNOWLEDGE: The study included 109,255 patients enrolled in various types of enhanced CT examinations, which could reflect ADR conditions and regulations in Chinese population accurately and reliably.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25582519      PMCID: PMC4651201          DOI: 10.1259/bjr.20140491

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  22 in total

1.  Management of acute adverse reactions to contrast media.

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-01-23       Impact factor: 5.315

Review 2.  Adverse reactions to intravenous iodinated contrast media: a primer for radiologists.

Authors:  Saravanan Namasivayam; Mannudeep K Kalra; William E Torres; William C Small
Journal:  Emerg Radiol       Date:  2006-05-11

3.  ESUR guidelines on contrast media.

Authors:  H S Thomsen; S K Morcos
Journal:  Abdom Imaging       Date:  2006 Mar-Apr

4.  Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital.

Authors:  Koenraad J Mortelé; Maria-Raquel Oliva; Silvia Ondategui; Pablo R Ros; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

Review 5.  Iodinated contrast media and their adverse reactions.

Authors:  Jagdish Singh; Aditya Daftary
Journal:  J Nucl Med Technol       Date:  2008-05-15

6.  Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.

Authors:  H Katayama; K Yamaguchi; T Kozuka; T Takashima; P Seez; K Matsuura
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

7.  Frequently asked questions: iodinated contrast agents.

Authors:  Michael A Bettmann
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

8.  Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children.

Authors:  Jonathan R Dillman; Peter J Strouse; James H Ellis; Richard H Cohan; Sophia C Jan
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

Review 9.  Current understanding of contrast media reactions and implications for clinical management.

Authors:  Marc J Meth; Howard I Maibach
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

10.  Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators.

Authors:  Shin-ichiro Narita; Randall M Goldblum; Cheryl S Watson; Edward G Brooks; D Mark Estes; Edward M Curran; Terumi Midoro-Horiuti
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

View more
  13 in total

1.  Safety incident reporting in emergency radiology: analysis of 1717 safety incident reports.

Authors:  Mohammad Mansouri; Khalid W Shaqdan; Shima Aran; Ali S Raja; Michael H Lev; Hani H Abujudeh
Journal:  Emerg Radiol       Date:  2015-08-06

2.  Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors.

Authors:  Xue Li; Heng Liu; Li Zhao; Junling Liu; Li Cai; Lei Liu; Weiguo Zhang
Journal:  Br J Radiol       Date:  2016-12-08       Impact factor: 3.039

Review 3.  Imaging of acute pulmonary embolism: an update.

Authors:  Alastair J E Moore; Jason Wachsmann; Murthy R Chamarthy; Lloyd Panjikaran; Yuki Tanabe; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

4.  How often are Patients Harmed When They Visit the Computed Tomography Suite? A Multi-year Experience, in Incident Reporting, in a Large Academic Medical Center.

Authors:  Mohammad Mansouri; Shima Aran; Khalid W Shaqdan; Hani H Abujudeh
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

5.  Nausea and vomiting after exposure to non-ionic contrast media: incidence and risk factors focusing on preparatory fasting.

Authors:  Yeon Soo Kim; Soon Ho Yoon; Young Hun Choi; Chang Min Park; Whal Lee; Jin Mo Goo
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

6.  Can the lower rate of CT- or MRI-related adverse drug reactions to contrast media due to stricter limitations on patients undergoing contrast-enhanced CT or MRI?

Authors:  Takahiro Maeda; Masafumi Oda; Shinji Kito; Tatsurou Tanaka; Nao Wakasugi-Sato; Shinobu Matsumoto-Takeda; Takaaki Joujima; Yuichi Miyamura; Koichi Kiyota; Kensuke Tsutsumi; Yasuhiro Morimoto
Journal:  Dentomaxillofac Radiol       Date:  2019-10-23       Impact factor: 2.419

7.  A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1-intravenous administration.

Authors:  Aart J van der Molen; Ilona A Dekkers; Ibrahim Bedioune; Elisabeth Darmon-Kern
Journal:  Eur Radiol       Date:  2022-03-21       Impact factor: 7.034

8.  Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China.

Authors:  Qin-Lan Chen; Xiao-Ying Zhao; Xiao-Mi Wang; Na Lv; Ling-Ling Zhu; Hui-Min Xu; Quan Zhou
Journal:  Ther Clin Risk Manag       Date:  2017-04-26       Impact factor: 2.423

9.  Acute Urticaria in Inpatients Undergoing Non-emergent Coronary Angiography With Corticosteroid Prophylaxis: A Retrospective Study.

Authors:  Bangtao Chen; Fubing Yu; WenChieh Chen; Yong Wang; Fei Hao
Journal:  Front Med (Lausanne)       Date:  2021-06-10

10.  Safety enhancement in adult body computed tomography scanning: comparison of iodixanol versus iohexol.

Authors:  Yong Xiao; Guofei Zeng; Xi Liu; Cong Peng; Changsu Lai; Peihua Zhou
Journal:  Springerplus       Date:  2016-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.